Midwest startups and fintech companies pulled in $213.5 million across six deals during the week ending Nov. 6, but the total tells a lopsided story. Two transactions of $100 million each made up nearly all of the money.
The data comes from StartMidwest's weekly funding roundup, as reported by Techli. Chicago-based AI infrastructure company Ocient and Columbus, Ohio-based Erebor Bank sat at the top of the list, while smaller rounds went to companies in health care technology, AI and financial services.
A Headline Number That Needs Context
One of the two largest deals was not a closed funding round. Japan's SBI Holdings announced a plan to invest $100 million in Erebor Bank, framing it as a commitment rather than a completed financing.
The roundup did not say when that investment is expected to be finalized. That distinction matters for anyone trying to measure how much capital has actually reached Midwest companies during the week.
Ocient Lands a $100 Million Series C
The largest completed round belonged to Ocient, which announced a $100 million Series C on Nov. 5. BOKA Capital and OCA Ventures led the deal, bringing the Chicago company's total funding to $260 million.
Returning backers included Greycroft, In-Q-Tel, Blue Bear Capital, Buoyant Ventures, PSP Growth, Pritzker Group Venture Capital and Eron Wolf. Dallas Venture Capital came in as a new investor.
Ocient builds data analytics and AI tools for enterprises handling very large data sets. The new capital will support its OcientAIQ products, which are designed to let companies run AI agents and analytics across petabyte-scale data environments.
Why Data Infrastructure Is Drawing Investors
As companies experiment with agentic AI systems that can analyze information and carry out tasks, dependable and well-governed data has become a core requirement. Ocient positions its platform as handling both data governance and high-performance analytics, so that AI agents and human analysts can query data inside a customer's own environment.
The company expects its revenue to more than triple in 2026, citing demand from customers with large and growing data volumes. That figure is a company projection, not a reported financial result.
Erebor Bank and the Smaller Rounds
Erebor Bank is a digital bank serving businesses in sectors such as AI, robotics, advanced manufacturing, defense and energy. Its planned SBI investment accounted for the other half of the week's two big deals.
In Chicago, University of Chicago spinout Focused Medical Technologies, which is developing a treatment for pulmonary embolism, raised $6 million from two strategic medtech investors and UCM Ventures. It plans to use the money for product development, manufacturing and preparation for a pivotal U.S. study.
Consumer insights company QualSights raised $5 million in a round led by Duo Partners and named Prasanna Pitale as chief executive. The company combines smart sensors, a consumer app and AI analytics to study how people use physical products.
Health care software startup CareLumi closed an oversubscribed $2.5 million pre-seed round led by Izou Partners, Fifth Star Funds and Chicago Early Growth Ventures. Its software monitors AI-driven and automated workflows in care delivery, beginning with provider credentialing and payer enrollment. Minneapolis-based Duome, which works with credit unions to help qualified buyers purchase homes through co-investment, rounded out the list with backing from Great Lakes Credit Union.
Chicago Leads, but the Totals Are Concentrated
Chicago accounted for four of the six deals, with Columbus and Minneapolis contributing one each. The sector mix stretched beyond conventional software into financial services, health care and AI infrastructure.
Still, the two $100 million deals represented about 94% of the reported total. The remaining four rounds together made up only a small slice of the week's capital.
What the Week Signals for Midwest Founders
The activity suggests investors remain interested in Midwest companies tackling infrastructure problems and industry-specific challenges. Large rounds like Ocient's show that later-stage capital is available for companies with traction.
The gap between those headline deals and the modest early-stage rounds raises a familiar question for the region: whether founders can count on steady access to capital at every stage, not just when a few large checks arrive in the same week.
Source: Techli
